• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Thoughts on Michael McMyne...













































mm now has knock knock jokes as part of his act. Could have used them at the nsm. Knock knock ulthera who's there just the guy about to offend your division for the next 30 min.
That was quite a Merz moment when mcmuffin did that. The best part was when HR made him go around and apologize to the Ulthera team in their breakout room..classless fool that rides coat tails and is obsessed with this board.
 




























That was quite a Merz moment when mcmuffin did that. The best part was when HR made him go around and apologize to the Ulthera team in their breakout room..classless fool that rides coat tails and is obsessed with this board.

Just heard MM got a ultherapy treatment,,,, now ulthera is apologizing to him. No results condolences presented to muffin.